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Bioethical issues
No Bioethical Committee consent was necessary for this 
study, as no study was performed on patients; all partici-
pants of the survey are coauthors of this manuscript and 
give their agreement for publication.
Statistical analysis
Categorical variables were compared with the chi-square 
test. Odds ratio (OR) and confidence intervals (95% CIs) 
were calculated for the difference in the rates of positive 
responses between this survey and the EBMT survey [3]. All 




All 23 Polish HCT centers participated in the survey, inclu-
ding six pediatric and 17 adult centers. The summary of 
responses provided by the centers, in comparison to the 
positive responses of the EBMT centers, is shown in Table I.
HEPA filters
Central or point-of-use HEPA filters with 99.97% efficiency 
for removing particles ≥0.3 mm in diameter ensuring safe 
ventilation of ≥12 air exchanges/hour is a standard of 
care in all Polish centers, both for allo-HCT and auto-HCT, 
including centers that perform auto-HCT only. All but one 
center have air-conditioning systems (ACs) exclusively 
designed for the transplant unit, and in the case of the 
single nonconforming center, the AC is shared with the 
hospital pharmacy. The majority (78%) of the centers 
declare regular replacement of HEPA filters, with variab-
le frequency, but at least once a year. This regularity is 
higher than those reported by the EBMT centers (odds 
ratio [OR] =3.8; 95% CI =1.3–11.0; p =0.018) [3]. Moreo-
ver, the majority of centers have a written procedure for 
filter maintenance and removal. GRPE recommendations 
require that filters should be replaced regularly based 
on manufacturers’ recommendations, and, when there 
is ongoing construction, filtration efficiency should be 
monitored frequently to best determine the appropriate 
time for replacement [1–3, 5].
Positive air pressure
Consistent positive air pressure differential between the 
patient’s room and the hallway of ≥2.5 Pa is required. Only 
34% of centers are equipped with a permanently installed 
device or mechanism to constantly monitor the differential 
air pressure between the room and the corridor, and even 
fewer centers are capable of monitoring the air pressure 
in the anteroom, in addition to the air pressure in the 
patient’s room. This rate is, however, exactly the same as 
in the EBMT survey [3]. Additionally, in 56% of centers, the 
Introduction
Hematopoietic cell transplantation (HCT) is one of the most 
immunosuppressive treatments performed currently in 
medicine. High level of protective environment is required 
for patients undergoing HCT to ensure safety of this treat-
ment in the transplant setting. International guidelines on 
transplant protective environment for health-care facilities 
regarding hospital room design and ventilation were propo-
sed as a set of 10 Global Recommendations on Protective 
Environment (GRPE) in 2009 [1, 2]. These guidelines were 
coordinated by the Center for International Blood and Mar-
row Transplant Research (CIBMTR), with the participation of 
the National Marrow Donor Program (NMDP), the American 
Society for Blood and Marrow Transplantation (ASBMT), the 
European Society for Blood and Marrow Transplantation 
(EBMT), the Infectious Diseases Society of America (IDSA), 
the Canadian Blood and Marrow Transplant Group (CBMTG), 
the Centers for Disease Control (CDC), the Association of 
Medical Microbiology and Infectious Disease (AMMI), and 
the Society for Healthcare Epidemiology of America (SHEA).
The objective of this study was to determine the current 
status on protective environment for HCT recipients in Po-
lish transplant centers and to report current practices in 
the hospital transplant setting, with focus on room design 




During the Transplant Workshop of the Polish Federation of 
Bone Marrow Transplant Centers in Poznań, on October 12, 
2019, a survey on antimicrobial prophylaxis and protective 
transplant environment was carried out, with one question-
naire administered per transplant center. The part of the 
survey on protective environment was based on the GRPE 
recommendations [1, 2] and was compared with the results 
obtained from the survey of EBMT centers, performed in 
2012 [3]. Results of the first part of the survey on anti-
microbial prophylaxis have been analyzed elsewhere [4].
Definitions
High efficiency particulate air (HEPA) filter — a high-efficien-
cy particulate air filter, with 99.97% efficiency in removing 
particles ≥0.3 mm in diameter with safe ventilation of ≥12 
air exchanges/hour. A laminar air flow room — a room 
containing HEPA-filtered air that moves in a parallel unidi-
rectional flow, such that the air enters the room from one 
side and exits this room from the other side. Combined 
room — a room designed for patients for isolation in order 
to protect them against airborne infections and provide 
specific protective environment by means of positive air 
pressure and laminar air flow [3].
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Table I. Overall positive results of the survey with respect to global recommendations on Protective Environment (GRPE)





1. Ventilation: ≥12 air changes per 
hour
AIII Does the room have at least 12 air 
changes per hour?
23 (100%) 126 (71.2%) ND
2. Central or point-of-use HEPA fil-
ters with 99.97% efficiency for remo-
ving particles ≤0.3 µm in diameter
AIII Are your patient rooms equipped 
with HEPA filters?
23 (100%) 176 (99.4%) ND
3. Filters should be replaced re-
gularly based on manufacturers’ 
recommendations, and, when there 
is ongoing construction, filtration 
efficiency should be monitored fre-
quently to best determine the appro-
priate time for replacement
AIII How often are the filters changed? 
(Response: regularly, at least once 
per year)
18 (78.3%) 52 (48.6%) OR =3.8, 
p =0.018
Do you have a written procedure for 
filter maintenance and removal?
15 (65.2%) 95 (53.7%) OR =1.6, 
p =0.41
Is a sensor monitor installed in the 
patient room, which is used to deter-
mine when the HEPA filters require 
changing?
8 (34.8%) 32 (18.1%) OR =2.4, 
p =0.10
4. Directed airflow so that air intake 
occurs at one side of the room and 
air exhaust occurs at the opposite 
side
BIII Is the airflow directed so that air in-
take occurs at one side of the room, 
while the air exhaust occurs at the 
opposite side?




5. Consistent positive air pressure 
differential between the patient’s 
room and the hallway of ≥2.5 Pa
BIII
Is there a permanently installed devi-
ce/mechanism to constantly monitor 
the differential air pressure between 
the room and the corridor?
8 (34.8%) 68 (38.4%) OR =0.9, 
p =0.91
6. Well-sealed rooms (e.g., filling the 
gaps between walls and windows, 
outlets, floor, and ceiling) should 
always be used for HCT patients to 
prevent infiltration of air from outsi-
de the room, which could allow entry 
of spores and hinder maintenance 
of proper pressure differential
BIII Are the room windows sealed to eli-
minate infiltration from outside?




Do the protective environment rooms 
have monolithic ceilings?
12 (52.2%) 62 (35.0%) OR =2.0, 
p =0.16
Are all plumbing pipes in the room 
sealed around wall penetrations?
12 (52.2%) 91 (51.4%) OR =1.0, 
p =0.94
7. Continuous pressure monitoring, 
especially while rooms are occupied
BIII Is there an air pressure-monitoring 
device/mechanism in the anteroom, 
in addition to the air pressure in the 
patient’s room?
5 (21.7%) 31 (17.5%) OR =1.3, 
p =0.83
8. Self-closing doors to maintain 
constant pressure differentials
BIII Are there self-closing doors to main-
tain constant pressure differentials?
10 (43.5%) 66 (37.3%) OR =1.3, 
p =0.72
9. Monitoring systems that will set 
off an alarm when the pressure dif-
ferential between any protective en-
vironment room and adjacent hall-
way or anteroom falls to <2.5 Pa, to 
alert staff to possible engineering 
failures
CIII Is there a monitoring system that will 
set off an alarm when the pressure 
differential between any protective 
environment room and adjacent 
hallway or anteroom falls to <2.5 Pa, 
to alert staff to possible engineering 
failures?
3 (13.6%) 60 (33.9%) OR =0.3, 
p =0.073
10. To enable the nursing staff to 
observe the HCT recipient even 
when the doors are closed, windows 
can be installed in either the door or 
the wall of the HCT recipient’s room
CIII Is the nursing staff able to observe 
the patient even when the doors are 
closed?
17 (73.9%) 109 (61.6%) OR =1.8, 
p =0.35
*Not all centers responded to all questions; EBMT — European Society for Blood and Marrow Transplantation; OR — odds ratio; ND — not done; HEPA — high efficiency particulate air; HCT — hematopoietic cell 
transplantation
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airflow is directed such that air intake occurs at one side 
of the room, while the air exhaust occurs at the opposite 
side. However, only three (13.6%) centers have a monito-
ring system that sets off an alarm, especially while rooms 
are occupied, when the pressure differential between any 
protective environment room and the adjacent hallway 
or anteroom falls to <2.5 Pa, in order to alert the staff to 
possible engineering failures. Nevertheless, these figures 
are also comparable to the results of the EBMT survey [3].
Well-sealed rooms
Rooms having monolithic ceilings and well-sealed walls 
and floor should always be used for HCT patients to prevent 
infiltration of air from outside the room, which could allow 
entry of spores and hinder maintenance of proper pressure 
differential. This is also relevant for any plumbing pipes 
in the room and anteroom. More than half of the centers 
reported having these technological solutions, with the rate 
being comparable to the results of the EBMT survey [3].
Self-closing doors
In order to maintain constant pressure differentials, 
self-closing doors additionally can secure the protective 
environment. This is a routine in 43.5% Polish centers. In 
European centers, it is not more frequent [3].
Observing HCT recipients
In a vast majority of centers, the nursing staff is able to 
observe the HCT recipient even when the doors are closed. 
This is possible due to the presence of monitoring systems 
with cameras; in other centers, windows are installed in 
either the door or the wall of the HCT recipient’s room.
Clinical implications of results of the survey
All Polish transplant centers together have created the 
Polish Federation of Bone Marrow Transplant Centers and 
actively cooperate at the organizational, medical, educa-
tional, and scientific levels. This survey shows that there 
are some differences in technological solutions among the 
centers. The differences might result from the different pe-
riods of establishment of transplant units: possibly, newer 
units are built more innovatively and equipped better than 
the older ones. It should be kept in mind that the survey 
was answered by physicians exclusively, without contact 
with supporting technical staff. It is highly probable that 
physicians and other health-care personnel of the trans-
plant unit do not have access to the necessary information 
on technical issues in their own center. Nevertheless, all 
centers ensure proper isolation of the transplant patient, as 
well as proper room ventilation with the use of HEPA filters. 
The quality of medical service was additionally confirmed by 
the first accreditations for chimeric antigen receptor (CAR) 
T-cell therapy in several Polish transplant centers [6, 7].
The limitation of the study is the small number of trans-
plant centers in Poland, disabling any further comparisons, 
e.g., pediatric vs adult centers. Furthermore, the survey was 
not aimed at any microbiological procedures ensuring pro-
tective environment. Nevertheless, regular microbiological 
screening for bacterial and fungal colonization should be 
performed inside the ward.
Conclusion
The results of this survey confirm that safe and protective 
patient isolation and protective environment are provided 
in all Polish transplant centers at the level that meets the 
required international standards.
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